| Dr Charles John Galanis, MD | |
|
416 N Bedford Dr Ste 311, Beverly Hills, CA 90210-4309 | |
| (312) 995-9822 | |
| Not Available |
| Full Name | Dr Charles John Galanis |
|---|---|
| Gender | Male |
| Speciality | Plastic Surgery |
| Location | 416 N Bedford Dr Ste 311, Beverly Hills, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407902190 | NPI | - | NPPES |
| 1407902190 | Medicaid | CA |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Charles John Galanis, MD 416 N Bedford Dr Ste 311, Beverly Hills, CA 90210-4309 Ph: (617) 991-7392 | Dr Charles John Galanis, MD 416 N Bedford Dr Ste 311, Beverly Hills, CA 90210-4309 Ph: (312) 995-9822 |
News Archive
Spinach and kale are favorites of those looking to stay physically fit, but they also could keep consumers cognitively fit, according to a new study from University of Illinois researchers.
In record time of two months, Pragmedic Solutions - a Dubai and US-based healthcare software solutions provider has successfully implemented the Healthcare Information System (HIS) for Emaar Healthcare Group, the healthcare subsidiary of Emaar Properties, it was announced today.
A new invention may be on the verge of replacing a costly cranial surgical procedure currently being performed on some traffic accident victims and other patient groups. The ultrasound-based technology has now been granted CE approval for the European market.
It is very difficult to predict whether a cancer drug will help an individual patient: only around one third of drugs will work directly in a given patient. Researchers at the Heinz Nixdorf Chair for Medical Electronics at the Technische Universitaet Muenchen (TUM) have developed a new test process for cancer drugs.
DiagnoCure, Inc., a life sciences company that develops and commercializes highâvalue cancer diagnostic tests, announced today that Gen-Probe Incorporated, its commercial partner for the PCA3 test, received notice from the U.S. Food and Drug Administration (FDA) that the PROGENSA PCA3 Assay will not be reviewed by the Immunology Panel of FDA's Medical Devices Advisory Committee on October 14, 2011 as previously scheduled, but will be reviewed by the Panel at a later date.
› Verified 3 days ago
Dr. Garo Kassabian, M.D., F.A.C.S. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 436 N Bedford Dr, Suite 301-302, Beverly Hills, CA 90210 Phone: 310-285-0400 Fax: 310-285-0222 | |
Dr. Leslie H Stevens, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 201 S Lasky Dr, Beverly Hills, CA 90212 Phone: 310-556-1003 | |
Dr. Ruben B Abrams, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 9301 Wilshire Blvd Ste 402, Beverly Hills, CA 90210 Phone: 310-276-7777 Fax: 310-388-5258 | |
Dr. Anita C Patel, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 9730 Wilshire Blvd Ste 104, Beverly Hills, CA 90212 Phone: 310-205-0212 Fax: 310-388-3138 | |
Dr. William James Rahal, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 465 N Roxbury Dr, Ph Suite, Beverly Hills, CA 90210 Phone: 424-278-2214 | |
Dr. Neil Menelaos Vranis, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 433 N Camden Dr Ste 780, Beverly Hills, CA 90210 Phone: 310-275-1959 Fax: 310-299-8646 | |
Mr. Payman Joseph Danielpour, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 436 N. Bedford Drive, Suite 308, Beverly Hills, CA 90210 Phone: 310-275-6600 Fax: 310-275-6607 |